Finance

Lists
CRVO:NASDAQ
CervoMed Inc
$2.73
-6.83%
(-0.20) 1D
$2.78
+1.85% (+0.050)
After hours
Closed: Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRVO...
Open
$2.99
High
$2.99
Low
$2.68
Mkt. cap
41.28M
Avg. vol.
466.61K
Volume
608.53K
52-wk high
$11.25
52-wk low
$2.15
EPS
-$3.21
Beta
-0.63
Shares outstanding
15.12M
No. of employees
15
Open
$2.99
High
$2.99
Low
$2.68
Mkt. cap
41.28M
Avg. vol.
466.61K
Volume
608.53K
52-wk high
$11.25
52-wk low
$2.15
EPS
-$3.21
Beta
-0.63
Shares outstanding
15.12M
No. of employees
15
About CervoMed Inc
CEO-
Employees15
Founded1995
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitecervomed.com
Analyst ratings
Based on 5 analysts giving stock ratings to CRVO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CRVO in the last 3 months.
Highest
Current $2.73
$25.00 (+815.75%)
Average
$17.00 (+522.71%)
Lowest
$9.00 (+229.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$25.00
+815.8%
08/12/2026
Boris Peaker
JonesTrading
Buy
Reiterated
$12.00
+339.6%
08/10/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$18.00
+559.3%
08/12/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$9.00
+229.7%
08/05/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$21.00
+669.2%
05/17/2026
Soumit Roy
JonesTrading
Buy
Maintained
$20.00
+632.6%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
322.57K
8.73K
-
-
Cost of goods sold
6.04M
5.83M
5.14M
137.18K
Cost of revenue
6.04M
5.83M
5.14M
137.18K
Research and development expenses
-
-
-
4.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.33M
2.51M
2.98M
2.36M
Operating expense
2.33M
2.51M
2.98M
6.54M
Total operating expenses
8.37M
8.34M
8.11M
6.68M
Operating income
-8.04M
-8.33M
-8.11M
-6.68M
Other non operating income
-1.23K
3.29K
-1.02K
2.00K
EBT including unusual items
-7.73M
-8.09M
-7.96M
-6.57M
EBT excluding unusual items
-7.73M
-8.09M
-7.96M
-6.57M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.73M
-8.09M
-7.96M
-6.57M
Net profit margin
-2,395.34%
-92,680.38%
-
-
Earnings per share
-0.84
-0.88
-0.86
-0.64
Interest and investment income
318.79K
240.94K
147.39K
104.90K
Interest expense
-
-
-
-
Net interest expenses
318.79K
240.94K
147.39K
104.90K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps